NCT05849584

Brief Summary

The aim of this observational study is to learn about how muscle dimensions of the pelvic floor measured during pregnancy in primigravida impact birth mecanics and mode of delivery. Tha main aims are to 1. Explore associations between mode of delivery and hiatal dimensions measured by transperineal ultrasound antenatally and 2. Explore the association between duration of 2nd stage of labour and hiatal dimensions. A pelvic floor ultrasound examination will be performed between pregnancy week 12 and 20 and levator ani muscle hiatal dimensions will be compared between women having a normal vaginal delivery and women with emergency cesarean or operative vaginal deliveries.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Feb 2024

Geographic Reach
1 country

2 active sites

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 19, 2023

Completed
4 months until next milestone

First Posted

Study publicly available on registry

May 9, 2023

Completed
9 months until next milestone

Study Start

First participant enrolled

February 5, 2024

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2025

Completed
Last Updated

June 24, 2025

Status Verified

June 1, 2025

Enrollment Period

1.7 years

First QC Date

January 19, 2023

Last Update Submit

June 17, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • Mode of delivery

    Normal vaginal, vacuum assisted vaginal, forceps assisted vaginal or emergency cesarean delivery

    Assessed at 1 day of childbirth

  • Levator hiatal dimensions

    levator hiatal anteroposterior diameter and levator hiatal area at rest measured with 2D and 3D ultrasound

    Measured in pregnancy week 12

  • Levator hiatal dimensions

    levator hiatal anteroposterior diameter and levator hiatal area at rest measured with 2D and 3D ultrasound

    Measured in pregnancy week 18

Secondary Outcomes (5)

  • Duration of second stage of delivery

    Assessed at 1 day of childbirth

  • Pernineal tears

    Assessed at 1 day of childbirth

  • Postpartum haemorrage

    Assessed at 1 day of childbirth

  • womans experience of transperineal ultrasound

    Assessed at pregnancy week 12 and week 18

  • Interrater validity of ultrasound measurements

    Assessed 3 months after childbirth

Study Arms (1)

Pregnant women

Other: Transperineal ultrasound

Interventions

A 2D scan will be performed of one experienced clinician. The average of 3 2D levator hiatal anteroposterior measurements will be stored. Then, a 3D/4D ultrasound examination of the pelvic floor will be performed using a Voluson S10, E8 or E10 (GE healthcare, Zipf, Austria) device with a RAB 4-8 MHz curved array transducer with the acquisition angle set at 85 degrees. Offline analysis of the ultrasound volumes will be performed using the 4D view (GE Healthcare, Austria) software, blinded to all clinical data. Hiatal anteroposterior diameter will be measured in both 2D and 3D. Hiatal area and hiatal transverse diameter will be measured in the 3D volume

Pregnant women

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

400 nulliparous pregnant women recruited at routine ultrasound scan i nearly pregnancy

You may qualify if:

  • Age over 18 years
  • Ability to consent
  • Singleton pregnancy

You may not qualify if:

  • Previous deliveries \> 16 weeks gestation
  • Previous pelvic floor surgery
  • Anomalies affecting the pelvic floor function (such as myelomeningocele)
  • Epilepsy, since this might influence intervention during delivery
  • Women with elective cesarean

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Levanger Sykehus

Levanger, Norway

Location

st.Olavs hospital

Trondheim, Norway

Location

MeSH Terms

Conditions

Rupture

Condition Hierarchy (Ancestors)

Wounds and Injuries

Study Officials

  • Ingrid Volløyhaug, PhD

    St. Olavs Hospital

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
2 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 19, 2023

First Posted

May 9, 2023

Study Start

February 5, 2024

Primary Completion

October 1, 2025

Study Completion

October 1, 2025

Last Updated

June 24, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations